The WACC of Travere Therapeutics Inc (TVTX) is 7.9%.
| Range | Selected | |
| Cost of equity | 7.40% - 9.60% | 8.50% |
| Tax rate | -% - 0.10% | 0.05% |
| Cost of debt | 4.00% - 7.00% | 5.50% |
| WACC | 6.7% - 9.1% | 7.9% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.76 | 0.85 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.40% | 9.60% |
| Tax rate | -% | 0.10% |
| Debt/Equity ratio | 0.23 | 0.23 |
| Cost of debt | 4.00% | 7.00% |
| After-tax WACC | 6.7% | 9.1% |
| Selected WACC | 7.9% | |